Search

Your search keyword '"ROSSING, PETER"' showing total 2,709 results

Search Constraints

Start Over You searched for: Author "ROSSING, PETER" Remove constraint Author: "ROSSING, PETER"
2,709 results on '"ROSSING, PETER"'

Search Results

2. Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case–control study

5. CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

7. Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.

8. Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).

10. The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases

11. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

21. Identification of biomarkers for glycaemic deterioration in type 2 diabetes

22. CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

26. Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

28. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race

29. Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials

30. A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population

31. Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline

36. Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial

43. Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis

45. Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial

47. Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working Group

48. Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

Catalog

Books, media, physical & digital resources